🇳🇱 Netherlands Country × Condition
cardiovascular diseases Clinical Trials in Netherlands
Active clinical trials for cardiovascular diseases with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT04241328
Recruiting
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
Enrollment
5,000 pts
Country
🇳🇱 Netherlands
Medtronic Cardiac Surgery
View Trial → NCT07304817 Phase 2
Recruiting
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Enrollment
100 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial → NCT06115759
Recruiting
RCT on T-REX Twente Regimen Effects on Quality of Life and Mobilisation for Cardiac Surgery Patients After Sternotomy
Enrollment
154 pts
Country
🇳🇱 Netherlands
Medisch Spectrum Twente
View Trial → NCT06412250
Recruiting
A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
Enrollment
2,000 pts
Country
🇳🇱 Netherlands
Translumina Therapeutics Pvt Ltd.
View Trial → Frequently Asked Questions
How many cardiovascular diseases clinical trials are active in Netherlands?
There are currently 4 active clinical trials for cardiovascular diseases with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a cardiovascular diseases clinical trial in Netherlands?
To join a cardiovascular diseases clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cardiovascular diseases trials in Netherlands?
Active cardiovascular diseases trials in Netherlands span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology